Heparan sulfate proteoglycan-involving immunomodulation by cathelicidin antimicrobial peptides LL-37 and PR-39

被引:15
|
作者
Kaneider, Nicole C. [2 ]
Djanani, Angela [2 ]
Wiedermann, Christian J. [1 ]
机构
[1] Ctr Hosp Bolzano, Dept Internal Med, Div Internal Med 2, Bolzano, Italy
[2] Med Univ Innsbruck, Dept Internal Med, Div Gen Internal Med, Innsbruck, Austria
来源
关键词
inflammation; host defense; glycosaminoglycans; cell-matrix interaction; cell signalling;
D O I
10.1100/tsw.2007.285
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
[No abstract available]
引用
收藏
页码:1832 / 1838
页数:7
相关论文
共 14 条
  • [1] Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin
    Djanani A.
    Mosheimer B.
    Kaneider N.C.
    Ross C.R.
    Ricevuti G.
    Patsch J.R.
    Wiedermann C.J.
    Journal of Inflammation, 3 (1)
  • [2] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425
  • [3] Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37
    Wang, Guangshun
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Zhang, Yingxia
    Wang, Fangyu
    Wang, Chunfeng
    Zarena, D.
    Lushnikova, Tamara
    Wang, Xiuqing
    ANTIMICROBIAL PEPTIDES: BASICS FOR CLINICAL APPLICATION, 2019, 1117 : 215 - 240
  • [4] In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37
    Sigurdardottir, Thorgerdur
    Andersson, Pia
    Davoudi, Mina
    Malmsten, Martin
    Schmidtchen, Artur
    Bodelsson, Mikael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2983 - 2989
  • [5] Resistome of Staphylococcus aureus in Response to Human Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides
    Golla, Radha M.
    Mishra, Biswajit
    Dang, Xiangli
    Narayana, Jayaram Lakshmaiah
    Li, Amy
    Xu, Libin
    Wang, Guangshun
    ACS INFECTIOUS DISEASES, 2020, 6 (07): : 1866 - 1881
  • [6] Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites
    Rico-Mata, Rosa
    De Leon-Rodriguez, Luis M.
    Avila, Eva E.
    EXPERIMENTAL PARASITOLOGY, 2013, 133 (03) : 300 - 306
  • [7] Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
    Krishnamoorthy, Rajavenkatesh
    Adhikari, Priyanka
    Anaikutti, Parthiban
    RSC ADVANCES, 2023, 13 (23) : 15594 - 15605
  • [8] Antimicrobial peptides cathelicidin (LL-37) ve hum β2 defensin levels of pediatric patients with bronchiolitis obliterans
    Gedik, Ahmet Hakan
    Cakir, Erkan
    Gokdemir, Yasemin
    Uyan, Zeynep Seda
    Kocyigit, Abdurrahim
    Torun, Emel
    Karadag, Bulent
    Ersu, Retika
    Karakoc, Fazilet
    Hakan, Ahmet
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] Elucidation of the Mechanisms of Human cathelicidin-derived Antimicrobial Peptides (LL-37 and its Truncated LL-31) Against Burkholderia Pseudomallei
    Phophetleb, Onanong
    Tun, Wonn Shweyi Thet
    Klaynongsruang, Sompong
    Daduang, Sakda
    Taweechaisupapong, Suwimol
    Patramanon, Rina
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2023, 29 (04)
  • [10] Elucidation of the Mechanisms of Human cathelicidin-derived Antimicrobial Peptides (LL-37 and its Truncated LL-31) Against Burkholderia Pseudomallei
    Onanong Phophetleb
    Wonn Shweyi Thet Tun
    Sompong Klaynongsruang
    Sakda Daduang
    Suwimol Taweechaisupapong
    Rina Patramanon
    International Journal of Peptide Research and Therapeutics, 29